A recent study reported that TILs infusion combined with lymphodepletion significantly increases CD11b+CD15+LOX-1+ PMN-MDSCs, which suppress TILs proliferation and IFN-γ production in melanoma and NSCLC patients (Innamarato et al., 2020). This evidence concerns the gene ITGAM and melanoma.